Michèle Provencher

8PUBLICATIONS
90CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 15, 2025
SMARCA4 regulates the NK-mediated killing of senescent cells.

Virinder Reen, Mariantonietta D'Ambrosio, Pia Pernille Søgaard

|Oct 03, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.

Jung-Min Lee, Mark F Brady, Austin Miller

|May 01, 2023
Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial.

Oliver Dorigo, Amit M Oza, Tanja Pejovic

|Feb 25, 2023
Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene.

Caitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya

|Jun 23, 2022
A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers.

Anna V Tinker, Alon D Altman, Marcus Q Bernardini

|Jun 06, 2022
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).

Bradley J Monk, Christine Parkinson, Myong Cheol Lim

Pageof 2

Frequent Collaborators

3 joint publications

Iain A McNeish

3 joint publications

Anne-Marie Mes-Masson

2 joint publications

Prafull Ghatage

2 joint publications

Rebecca S Kristeleit